ROS and TGFβ: from pancreatic tumour growth to metastasis

CH Chang, S Pauklin - Journal of Experimental & Clinical Cancer …, 2021 - Springer
Transforming growth factor β (TGFβ) signalling pathway switches between anti-tumorigenic
function at early stages of cancer formation and pro-tumorigenic effects at later stages …

The delicate equilibrium between oxidants and antioxidants in brain glioma

MJ Ramírez-Expósito… - Current …, 2019 - ingentaconnect.com
Gliomas are the most frequent brain tumors in the adult population and unfortunately the
adjuvant therapies are not effective. Brain tumorigenesis has been related both to the …

Emerging roles and therapeutic interventions of aerobic glycolysis in glioma

W Han, J Shi, J Cao, B Dong, W Guan - OncoTargets and therapy, 2020 - Taylor & Francis
Glioma is the most common type of intracranial malignant tumor, with a great recurrence rate
due to its infiltrative growth, treatment resistance, intra-and intertumoral genetic …

Current perspective on the natural compounds and drug delivery techniques in glioblastoma multiforme

T Behl, A Sharma, L Sharma, A Sehgal, S Singh… - Cancers, 2021 - mdpi.com
Simple Summary Glioblastoma multiforme (GBM) is one of the belligerent neoplasia that
metastasize to other brain regions and invade nearby healthy tissues. However, the …

KYP-2047, an inhibitor of prolyl-oligopeptidase, reduces glioblastoma proliferation through angiogenesis and apoptosis modulation

SA Scuderi, G Casili, A Ardizzone, S Forte, L Colarossi… - Cancers, 2021 - mdpi.com
Simple Summary Glioblastoma (GB) is the most aggressive brain tumor characterized by
necrosis, excessive proliferation, and invasiveness. Despite relevant progress in …

Manumycin A is a potent inhibitor of mammalian thioredoxin reductase-1 (TrxR-1)

A Tuladhar, KS Rein - ACS medicinal chemistry letters, 2018 - ACS Publications
The anticancer effect of manumycin A (Man A) has been attributed to the inhibition of
farnesyl transferase (FTase), an enzyme that is responsible for post-translational …

Down‐regulation of TFAM increases the sensitivity of tumour cells to radiation via p53/TIGAR signalling pathway

X Jiang, J Wang - Journal of cellular and molecular medicine, 2019 - Wiley Online Library
Mitochondrial transcription factor A (TFAM) is a key regulator of mitochondria biogenesis.
Previous studies confirmed that reduced TFAM expression sensitized tumours cells to …

Effectors of thioredoxin reductase: Brevetoxins and manumycin-A

A Tuladhar, RJ Hondal, R Colon, EL Hernandez… - … and Physiology Part C …, 2019 - Elsevier
The activities of two effectors, brevetoxin (PbTx) and manumycin-A (Man-A), of thioredoxin
reductase (TrxR) have been evaluated against a series of fourteen TrxR orthologs …

A low toxic synthetic dendrimer conjugated podophyllotoxin nanodevice with potent antitumor activity against the DMBA/TPA induced mouse skin carcinogenesis …

UH Sk, V Patial, S Sharma - Toxicology Research, 2015 - academic.oup.com
Natural podophyllotoxin (PODO) is an anticancer drug that functions as an anti-mitotic agent
and inhibits tubulin polymerization. However, high toxicity and low bioavailability limit its …

TIGAR inclusion pathology is specific for Lewy body diseases

KLR López, JE Simpson, LC Watson, H Mortiboys… - Brain research, 2019 - Elsevier
Background We previously reported up-regulation of tigarb (the zebrafish orthologue of
human TIGAR, TP53–Induced Glycolysis and Apoptosis Regulator) in a zebrafish pink1 …